HLB bioStep Co.,Ltd. (KOSDAQ:278650)

HLB bioStep Revenue

In the year 2025, HLB bioStep had annual revenue of 74.05B KRW with 27.30% growth. HLB bioStep had revenue of 18.73B in the quarter ending December 31, 2025, with 16.01% growth.

• Revenue: 74.05B
• Revenue Growth: +27.30%
• P/S Ratio: 1.36
• Revenue / Employee: 503.74M
• Employees: 147
• Market Cap: 100.60B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	74.05B	15.88B	27.30%
Dec 31, 2024	58.17B	5.35B	10.14%
Dec 31, 2023	52.81B	-33.46B	-38.79%
Dec 31, 2022	86.28B	21.87B	33.96%
Dec 31, 2021	64.40B	5.88B	10.05%